493 related articles for article (PubMed ID: 26601661)
21. Antifungal activity of Punicalagin-nystatin combinations against Candida albicans.
da Silva RA; Ishikiriama BLC; Ribeiro Lopes MM; de Castro RD; Garcia CR; Porto VC; Santos CF; Neppelenbroek KH; Lara VS
Oral Dis; 2020 Nov; 26(8):1810-1819. PubMed ID: 32583467
[TBL] [Abstract][Full Text] [Related]
22. In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre-Urizar JM; Quindós G; Eraso E
Biomed Pharmacother; 2021 Nov; 143():112218. PubMed ID: 34649348
[TBL] [Abstract][Full Text] [Related]
23. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
24. [Sensitivity of fungi of the genus Candida to antifungal drugs].
Sheremet ZA; Volosevich LI
Antibiot Khimioter; 1989 Apr; 34(4):263-6. PubMed ID: 2751383
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
Traboulsi RS; Mukherjee PK; Ghannoum MA
Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
[TBL] [Abstract][Full Text] [Related]
26. Fungal profile and antifungal susceptibility pattern in patients with oral candidiasis.
Sav H; Altinbas R; Dursun ZB
Infez Med; 2020 Sep; 28(3):392-396. PubMed ID: 32920575
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effects of tea polyphenol epigallocatechin 3-O-gallate and azole drugs against oral Candida isolates.
Behbehani JM; Irshad M; Shreaz S; Karched M
J Mycol Med; 2019 Jun; 29(2):158-167. PubMed ID: 30797684
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Sardi JC; Gullo FP; Freires IA; Pitangui NS; Segalla MP; Fusco-Almeida AM; Rosalen PL; Regasini LO; Mendes-Giannini MJ
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):387-391. PubMed ID: 27638348
[TBL] [Abstract][Full Text] [Related]
29. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
Wei GX; Xu X; Wu CD
Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
[TBL] [Abstract][Full Text] [Related]
30. Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida.
Mandras N; Nostro A; Roana J; Scalas D; Banche G; Ghisetti V; Del Re S; Fucale G; Cuffini AM; Tullio V
BMC Complement Altern Med; 2016 Aug; 16(1):330. PubMed ID: 27576581
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients.
Okechukwu DC; Momoh MA; Esimone CO
Afr Health Sci; 2015 Sep; 15(3):789-96. PubMed ID: 26957966
[TBL] [Abstract][Full Text] [Related]
32. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins.
de Castro RD; Mota AC; de Oliveira Lima E; Batista AU; de Araújo Oliveira J; Cavalcanti AL
BMC Oral Health; 2015 Apr; 15():52. PubMed ID: 25928798
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
Ning Y; Ling J; Wu CD
Arch Oral Biol; 2015 Oct; 60(10):1565-70. PubMed ID: 26263544
[TBL] [Abstract][Full Text] [Related]
35. Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms.
Powell LC; Adams JYM; Quoraishi S; Py C; Oger A; Gazze SA; Francis LW; von Ruhland C; Owens D; Rye PD; Hill KE; Pritchard MF; Thomas DW
Front Cell Infect Microbiol; 2023; 13():1122340. PubMed ID: 36798083
[TBL] [Abstract][Full Text] [Related]
36. Antifungal Activity, Mode of Action, Docking Prediction and Anti-biofilm Effects of (+)-β-pinene Enantiomers against Candida spp.
de Macêdo Andrade AC; Rosalen PL; Freires IA; Scotti L; Scotti MT; Aquino SG; de Castro RD
Curr Top Med Chem; 2018; 18(29):2481-2490. PubMed ID: 30430938
[TBL] [Abstract][Full Text] [Related]
37. Antifungal activity of coronarin D against Candida albicans.
Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
[TBL] [Abstract][Full Text] [Related]
38. Short-Term Antifungal Treatments of Caprylic Acid with Carvacrol or Thymol Induce Synergistic 6-Log Reduction of Pathogenic Candida albicans by Cell Membrane Disruption and Efflux Pump Inhibition.
Bae YS; Rhee MS
Cell Physiol Biochem; 2019; 53(2):285-300. PubMed ID: 31334617
[TBL] [Abstract][Full Text] [Related]
39. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
[TBL] [Abstract][Full Text] [Related]
40. Alkylphenol Activity against Candida spp. and Microsporum canis: A Focus on the Antifungal Activity of Thymol, Eugenol and O-Methyl Derivatives.
Fontenelle RO; Morais SM; Brito EH; Brilhante RS; Cordeiro RA; Lima YC; Brasil NV; Monteiro AJ; Sidrim JJ; Rocha MF
Molecules; 2011 Jul; 16(8):6422-31. PubMed ID: 25134762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]